Indoco Remedies · NSE: INDOCO · BSE: 532612
Q4 FY19 results · Jan–Mar 2019
Indoco Remedies reported revenue from operations of ₹252.02 crore and net profit of ₹11.63 crore for Q4 FY19 (Jan–Mar 2019), on a standalone basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 252.02 | — | — | 262.56 | −4.0% |
| Other income | 4.94 | — | — | 0.57 | +766.7% |
| Total income | 256.96 | — | — | 263.13 | −2.3% |
| Profit before tax | 9.40 | — | — | 3.90 | +141.0% |
| Net profit for the period | 11.63 | — | — | 5.34 | +117.8% |
| EPS, basic (₹) | 1.26 | — | — | 0.58 | +117.2% |
| Net margin (%) | 4.6 | — | 2.0 |
Standalone
- Filed with BSE
- 05 Jun 2019, 13:50 IST
- Board meeting
- 29 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE